Introducing PharmAlliance International Labs’ Piroxicam Range, offering innovative pain relief solutions. Piroxicam, a potent NSAID, effectively manages inflammation and pain through COX enzyme inhibition. Our Piroxicam Liquid Ampules (20 mg) ensure precise, rapid relief for conditions like arthritis, gout, and musculoskeletal disorders. Tailored dosages optimize safety and efficacy, providing sustained comfort with minimal side effects. Experience cutting-edge pain management with PharmAlliance’s Piroxicam Range.

Categories: ,


Introducing PharmAlliance International Labs Private Limited’s Piroxicam Range: Revolutionizing Pain Relief

Step into a realm of pharmaceutical excellence with PharmAlliance International Labs Private Limited’s Piroxicam Range, where innovation converges with compassion to redefine pain management and inflammation relief. As a beacon of trust and reliability in the healthcare landscape, we are dedicated to elevating patient care through the provision of cutting-edge pharmaceutical solutions that transcend boundaries and empower lives.

Understanding Drug Classification:

Piroxicam stands as a cornerstone within the esteemed class of nonsteroidal anti-inflammatory drugs (NSAIDs). Renowned for its potent anti-inflammatory, analgesic, and antipyretic properties, Piroxicam exerts its therapeutic prowess by intricately inhibiting the synthesis of prostaglandins through the targeted blockade of cyclooxygenase enzymes (COX-1 and COX-2). This multifaceted mechanism underscores its efficacy in managing a myriad of inflammatory and painful conditions.

Unveiling Formulations for Optimal Relief:

At the heart of our Piroxicam Range lies a hallmark formulation: Piroxicam Liquid Ampules. Each ampule houses 20 mg of Piroxicam in a meticulously crafted liquid solution designed for seamless intravenous or intramuscular administration. Packaged with precision and convenience in mind, every pack comprises 5 ampules, ensuring streamlined integration into clinical practice.

Indications: Empowering Patients on the Road to Recovery:

Piroxicam emerges as a stalwart ally in the battle against rheumatoid arthritis, osteoarthritis, acute gout, ankylosing spondylitis, and a myriad of soft tissue injuries and musculoskeletal disorders. From postoperative pain and inflammation to acute symptomatic relief, Piroxicam extends its healing touch to enhance patient well-being and comfort.

Guiding Usage for Optimal Outcomes:

With a steadfast commitment to patient safety and efficacy, Piroxicam Liquid Ampules are recommended for short-term use to manage acute symptoms of inflammation and pain. Healthcare professionals are entrusted with the responsibility of tailoring dosage regimens and route selection based on individual patient conditions, severity of symptoms, and treatment response.

Optimizing Dosage for Personalized Care:

Precision is paramount in the realm of Piroxicam administration. The recommended dosage typically ranges from 20 to 40 mg per day, administered in one or two divided doses. For acute conditions, an initial higher dose may be warranted followed by a lower maintenance dose. Dosage adjustments may be necessary in specific patient populations to mitigate the risk of adverse effects.

Navigating Pharmacokinetic Realms:

Embark on a journey through Piroxicam’s pharmacokinetic landscape, where absorption is rapid, distribution is extensive, and metabolism is intricate. With an elimination half-life of 30 to 50 hours, Piroxicam ensures sustained relief while minimizing the potential for adverse events.

Harmonizing Pharmacodynamics for Optimal Relief:

Piroxicam’s pharmacodynamic symphony unfolds with precision, orchestrating relief by staunchly inhibiting prostaglandin synthesis and mitigating pain, inflammation, and fever at their core. Through the targeted blockade of COX enzymes, Piroxicam champions patient comfort and well-being with unwavering resolve.

Prioritizing Safety Amidst the Pursuit of Relief:

While Piroxicam heralds a new era in pain management, vigilance remains paramount. Common side effects such as gastrointestinal disturbances and renal impairment underscore the importance of judicious monitoring and adherence to prescribed regimens. Through proactive risk management, we endeavor to mitigate the potential for serious adverse events and ensure patient safety above all else.


In conclusion, PharmAlliance International Labs Private Limited’s Piroxicam Range epitomizes a fusion of science, compassion, and innovation in the pursuit of pain relief excellence. As stewards of patient well-being, we invite you to embark on a transformative journey towards a future free from the shackles of pain. For more information on our Piroxicam Range and other pharmaceutical solutions, please don’t hesitate to contact us. Together, let’s forge ahead in our mission to redefine pain management and empower lives world.


There are no reviews yet.

Be the first to review “Piroxicam”

Your email address will not be published. Required fields are marked *

Pharmalliance.pkĀ© 2024. All rights reserved. Terms of use and Privacy Policy